Medical Supplies Reimagined
The medical supply chain is broken, and healthcare providers and patients are suffering as a result. iRemedy is working to solve that problem by creating one of the world’s largest and most powerful procurement marketplace — powered by our patented AI technology.
THIS IS THE FUTURE OF HEALTHCARE
MARKET LANDSCAPE
The Medical Supply Industry
The medical supplies market is projected to reach $163.5 billion by 2027 from $138.4 billion in 2022, at a CAGR of 3.4% during the forecast period. The growth in this market is driven by the increasing demand for infection control measures to control hospital-acquired infections, increasing demand for medical devices, increasing number of ICU beds in hospitals and surgical centers, and rising number of accidents and trauma cases.
$138B+
USA MEDICAL SUPPLIES MARKET
5000
Hospital and Care Establishments
9,750
SURGERY CENTERS
230,000
PHYSICIAN OFFICES
COMPETITIVE ADVANTAGE
What Makes iRemedy Different From Others?
The typical medical supplier in the United States is over 100 years old. They were born before most homes had electricity and TVs, and before IBM built their first computer in 1953. And they still operate that way. We were born into a world that conquers complex problems with state-of-the-art, AI-driven technology. Our catalog is one of the largest, smartest public medical supply catalog in the world, with over 500,000 products and growing. We solve complex pricing, contracting, and sourcing problems — automatically.
THE PROBLEM
The Medical Supply Industry Is Broken
iRemedy has assembled the best of the best for a winning team. From Microsoft to Amazon, to multiple successful exits, the iRemedy team we feel are positioned to continue to grow this multi-million dollar company into a medical supply giant.
Hidden costs
Going with a legacy supplier means pricing fluctuations and tacked-on fees add up quickly, causing customers to dramatically overspend.
Global supply chain issues
It doesn’t take much disruption to upend global manufacturing and shipping, which ends up causing mass shortages and disastrous delays. Today’s medical suppliers haven’t invested in the technology to track and predict these changes before they happen.
Negative customer experience
People expect a modern buying experience at home and at work. Only iRemedy simplifies complex medical supply purchasing through AI-powered design and interface.
THE SOLUTION
Smart. Transparent. Revolutionary.
Patients and healthcare providers deserve the peace of mind that comes from knowing they have what they need, when they need it most. They deserve to reach their health goals. They deserve to offer patients the best care possible. That’s where iRemedy comes in.
Transparent pricing
No hidden costs or fees. No surprises. Just the best price available for the products you need.
Easy ordering
Simple, fast, and secure. Our interfaces are user-friendly and direct — what you see is what you get. No more faxes, confusing order forms, or hours on hold with customer service.
Constant supply monitoring
iRemedy uses groundbreaking AI to track inventories, shipments, and manufacturers 24/7. Customers can easily stay aware of shortages, so they don’t waste valuable time and money.
90% of All Medical Supplies are Sourced in Asia
iRemedy’s mission is to focus on more domestic supply and a more resilient global supply chain.
Health and medical supplies delivered fast, when you need them most.
Join the movement in the AI-powered medical marketplace disrupting the $130 billion medical supply market.
OPPORTUNITY
The Time For Change is Now.
There’s never been a better time to empower patients and healthcare providers with a service that will not only make their lives easier but will literally save lives. When you invest in iRemedy, you’re investing in the future of healthcare — an industry desperate for revolutionary modernization. Be a part of this incredible technology-fueled step forward. Join our growing community of investors today.
COMPETITIVE ADVANTAGE
Revolutionize the Broken and Corrupt Medical Industry With Us
Having access to medical supplies can be an issue of life or death. Waiting is not an option, and going through red tape only makes helping people harder. The medical supply industry is failing patients. iRemedy has a disruptive solution to transform the industry. Our catalog is one of the largest, smartest public medical supply catalog in the world, with over 500,000 products and growing. We solve complex pricing, contracting, and sourcing problems — automatically. The gold standard is here, and it’s going to change everything.
THE TEAM
Executive Leadership Team
iRemedy has assembled the best of the best for a winning team. From Microsoft to Amazon, to multiple successful exits, the iRemedy team is positioned to continue to grow this multi-million dollar company into a medical supply giant.
Tony Paquin
CEO
- Founder and CEO, Agency One / AMS; Sold to CNA Insurance
- Founder and CEO, Medinex; IPO on Nasdaq
- Ten-year advisor to C-Suite healthcare leaders
- Twelve patents filed, three issued
- Author of two healthcare books
Jim Harding
CTO
- One of the creators of PC-DOS, licensed to Microsoft
- VP Technology, Amazon; built and launched the Amazon Marketplace
- Sold two companies to Amazon (Cartia, PhotoTrust)
- Sixteen patents filed, six issued
IREMEDY REVENUE
iRemedy Current Revenue
REVENUE
REVENUE
REVENUE
REVENUE
REVENUE
Our Physician and Healthcare Professional Investors
- Dr. Pavan Anand | Internal Medicine
- Dr. Sumit Bhatla |Interventional Radiology
- Dr. Vivian B. Bilasano | Internal Medicine
- Dr. Marc Braman | Preventative Medicine & Public Health
- Dr. Hal Brown | Family Medicine
- Dr. Donald Chadwell | Physical Medicine & Rehabilitation
- Dr. Won Chae |Radiology
- Dr. Abdulrahman Chahin | Internal Medicine
- Dr. Abdullah Chahin | Internal Medicine
- Dr. Stephanie A. Chuipek | Pediatric Medicine
- Dr. Jeffrey S. Clarke | Critical Care Medicine
- Dr. Derek Tan Dee | Orthopaedic Surgery
- Dr. Brian J. Deonarine | Cardiology; Cardiovascular Medicine; Internal Medicine
- Dr. Michael A. DeVito | Podiatry
- David W. Donahower, President | Chesapeake Surgery
- Dr. Mohamed El-Jack | Urology
- Dr. Kevin Fleishman | Obstetrics & Gynecology
- Dr. Nicole G. Freels | Podiatry
- Dr. Glenn S. Fuocco | Physical Medicine & Rehabilitation
- Dr. Charles S.C. Garnette | Vascular Surgery & Endovascular Surgery
- Dr. Martin L. Gelman | Internal Medicine & Nephrology
- Dr. George W. Ginter | Anesthesiology
- Dr. Nicholas Roy Goucher | Orthopaedic Surgery
- Dr. Brian Haas | Ophthalmology & Plastic Surgery
- Dr. Jason Harris | General Surgery
- Dr. Douglas Hertford | Radiology
- Dr. James S. Hoyt | Selah Ridge Ventures
- Dr. Oliver Jenkins | Otolaryngology
- Dr. Robert L. Kalb | Orthopaedic Surgery
- Dr. Magdalene Karon | Obstetrics & Gynecology
- Dr. Leo M. Keegan | Aesthetic Surgery
- Dr. Todd E. Kimball | Optometry
- Dr. Raymond Kordonowy | Internal Medicine; Clinical Lipidology
- Dr. Joe Krause | Nephrology & Internal Medicine
- Dr. Romana Kulikova | Pediatric Neurology
- Dr. Todd Kupferman | Otolaryngology
- Dr. Marc Lederman | Podiatry
- Dr. John D. Looff | Obstetrics & Gynecology
- Dr. Hector Lozano | Cardiology
- Dr. Joseph Magnant | Vascular Surgery
- Dr. Michele S. Maholz | Pulmonology; Sleep & Internal Medicine
- Dr. Edgar O. Mandeville | Obstetrics & Gynecology
- Dr. Bryan C. Markinson | Podiatry
- Dr. Jackie Matar | Radiation Oncology
- Dr. James R. Mault | Cardiothoracic Surgery & General Surgery
- Dr. Michael Maynard | Orthopaedic Surgery & Sports Medicine
- Dr. Brian Mitchell | Hematology & Oncology
- Dr. Manthey Mitchell | Internal Medicine
- John Mullins, President, Marshall Lifestyle Medicine | General Medicine
- Dr. Lakshmi Naidu | Internal Medicine
- Dr. Qefli Neziri | Internal Medicine
- Dr. Robert Craig Palumbo | Orthopaedics & Sports Medicine
- Eugene Pantangco, President | GI & Liver Diseases of Newport
- Dr. Christopher Perry | Rhinoplasty & Otolaryngology
- Dr. Jay A. Redan | General Surgery
- Dr. Rick Redalen | Retired
- Dr. Kirk Reichard | Pediatric Surgery
- Dr. Sara Reichard | Obstetrics & Gynecology
- Dr. Cheryl S. Reynolds | Emergency Medicine & Family Medicine
- Dr. Deepti Sadhwani | Internal Medicine
- Dr. Harish Sadhwani | Internal Medicine
- Dr. Dennis F. Saver | Family Medicine & Geriatric Medicine
- Dr. Hani B. Seifein | Cardiology; Nuclear & Interventional Cardiology
- Dr. Richard Seldes | Orthopaedic Surgery
- Dr. Eric T. Shapiro | Orthopaedic Surgery
- Dr. Gary Silber | Pediatric Gastroenterology
- Dr. William J. Simons | Infectious Disease Medicine
- Dr. Wayne Sinclair | Asthma & Allergy
- Dr. Douglas F. Smith | Radiology
- Dr. Vineel Sompalli | Interventional Cardiology
- Dr. Albert Speech | Nose & Throat
- Dr. William Spielfogel | Podiatry
- Dr. Howard Staniloff | Cardiology
- Dr. Jason Stern |Hematology & Oncology
- Dr. John D. Steward | General Surgery
- Dr. David Theil | Anesthesiology
- Dr. John Thurman | Internal Medicine
- Dr. Nancy Thurman-Watson | Anesthesiology
- Dr. Francisco Torres | Interventional Psychiatry; Physical Medicine & Rehabilitation
- Dr. Guy Ulrich | Internal Medicine
- Dr. Guy Ulrich | Internal Medicine
- Dr. Thomas Von Unrug | Internal Medicine
- Dr. Ballard Wright | Anesthesiology
- Dr. Peter Wright | Pain Management
- Dr. Mary Yankaskas |Obstetrics & Gynecology
JOIN TODAY AND MAKE A CHANGE
Invest in iRemedy
iRemedy will soon change forever the way medical supplies are sourced in the United States. Confusing prices, product shortages, and outrageous costs will be a thing of the past as we modernize the supply chain with artificial intelligence. Now is the time.
Updates
Company Updates
-
iRemedy Announces Patent Grant by US Patent Office
STUART, FL – (GLOBE NEWSWIRE) – June 26, 2023 – The iRemedy Healthcare Companies, Inc.... -
iRemedy And Verséa Health Announce Strategic Joint Venture
Companies to Launch Integrated Supply Purchasing and Service Platform for Urgent Care CentersSTUART, FLORIDA, U.S,... -
Podcast iRemedy Debuts “The Supply Side“ Podcast, Unveiling Insights into the Medical Supply Chain and Healthcare Industry
STUART, FL – June 15, 2023 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the...
Faq's
General FAQ
We believe there are two great reasons to invest in iRemedy Healthcare. First, healthcare costs in America are among the highest in the world and a major factor in that cost is the non-competitive nature of medical supply sales. Investing in iRemedy Healthcare is a way to participate in a new model of lower medical supply costs and subsequently, lower healthcare costs in America. Secondly, the medical supply industry is one of the largest vertical markets in the country with sales exceeding $100B. The timing is excellent to utilize a new AI marketplace platform to achieve continued rapid sales growth.
As a healthcare professional you will be able to be an owner and participant in the company from which you purchase your medical supplies. Also, owners in iRemedy Healthcare qualify for a discount on their medical supply purchasing as well as free shipping.
The founders and senior executives of iRemedy Healthcare have had multiple successful exits including acquisitions and a NASDAQ public offering. The executive team is committed to an expeditious successful exit, either via acquisition or IPO.
Our offering is open to US and international investors.
You can view our offering circular at the link below. We recommend you read it before investing:
<Insert link to circular offering>
Contact iRemedy Healthcare directly for a phone consultation or further information.
<Insert contact link>
Let us know if you have any additional questions.
iRemedy Healthcare has a proprietary AI driven marketplace protected by patents issued and patents filed/pending. There are many ‘legacy’ vendors in medical supply distribution but none that are manufacturer, distributor, vendor, and product agnostic.
Proceeds from this offering will be used to further develop iRemedy’s AI Marketplace technology and expand the company’s sales and marketing teams.
iRemedy Healthcare plans on expanding our medical supply distribution business to encompass worldwide sourcing and distribution of products largely due to our proprietary AI marketplace platform.